key: cord-0894404-wkaubj8b
authors: Liu, Fuxiao; Lin, Jiahui; Wang, Qianqian; Shan, Hu
title: Rescue of recombinant canine distemper virus that expresses S1 subunit of SARS-CoV-2 spike protein in vitro
date: 2021-07-26
journal: Microb Pathog
DOI: 10.1016/j.micpath.2021.105108
sha: a0243dba0514fd1b7f48cb884d3bebadee41867f
doc_id: 894404
cord_uid: wkaubj8b

The coronavirus disease 2019 (COVID-19), as an unprecedented pandemic, has rapidly spread around the globe. Its etiological agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belongs to the genus Betacoronavirus in the family Coronaviridae. The viral S1 subunit has been demonstrated to have a powerful potential in inducing protective immune responses in vivo. Since April 2020, farmed minks were frequently reported to be infected with the SARS-CoV-2 in different countries. Unfortunately, there has been no available veterinary vaccine as yet. In this study, we used reverse genetics to rescue a recombinant canine distemper virus (CDV) that could express the SARS-CoV-2 S1 subunit in vitro. The S1 subunit sequence was demonstrated to be relatively stable in the genome of recombinant CDV during twenty serial viral passages in cells. However, due to introduction of the S1 subunit sequence into CDV genome, this recombinant CDV grew more slowly than the wild-type strain did. The genomic backbone of recombinant CDV was derived from a virulence-attenuating strain (QN strain). Therefore, if able to induce immune protections in minks from canine distemper and COVID-19 infections, this recombinant would be a potential vaccine candidate for veterinary use.

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory 46 syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread worldwide, overburdening health 47

The rCDV-S1 was harvested at passage-10 (P10) for extraction of viral RNA, which was 113 used as template for RT-PCR analysis using the PrimeScript™ High Fidelity One

Step RT RT-PCR and PCR products were detected by agarose gel electrophoresis, followed by Sanger 122 sequencing for analyzing the RT-PCR product. 123 2.5. Indirect immunofluorescence assay (IFA) of rCDV-S1 124 A VDS cell monolayer was infected with the P15 rCDV-S1 for 24 h, and then fixed in 4% 125 paraformaldehyde at room temperature for 30 min. After fixation, cells were washed four times 126 with PBS, and then permeated with 0.4% Triton X-100 at room temperature for 30 min. After 127 permeation, cells were washed three times with PBS and blocked in blocking solution at 37 °C for 128 control, the non-infected cell monolayer was subjected to the same treatments. 134 2.6. Mass spectrometry of S1 subunit expression 135

The culture supernatant of P10 rCDV-S1 was inactivated by 0.1% formalin at 4 °C for 48 h, 136 and subsequently subjected to mass spectrometry (MS) at the Shanghai Bioprofile Biotechnology 137

Co., Ltd (Shanghai, China), as described previously [15] . Briefly, protein digestion was performed 138 with a method of filter-aided sample preparation [16] . Liquid chromatography linked to tandem 139 mass spectrometry (LC-MS/MS) was performed on a Q Exactive Plus mass spectrometer that was 140 coupled to Easy nLC (Thermo Fisher, Waltham, MA, USA). The MS data were analyzed using 141

MaxQuant software v1.6.0.16. The database search results were filtered and exported with <1% 142 false discovery rate at peptide-spectrum-matched level, and protein level, respectively. 143 2.7. Growth kinetics of rCDV-S1 144 VDS cells were seeded into five 12-well plates (10 6 cells/well, and 3 wells/plate) for 145 incubation at 37 °C for 2 h. The P15 rCDV-S1 was inoculated (MOI = 0.0002) into all plates for 146 incubation at 37 °C for 3 h, and then supernatants were replaced with DMEM for further 147 incubation at 37 °C. At 0, 24, 48, 72 and 96 h post infection (hpi), any of plates was randomly 148 removed from the incubator, and subjected to two freeze-and-thaw cycles to collect supernatant 149 for viral titration using the Spearman-Kärber equation [17] . The wt-CDV as a control was 150 subjected to the same treatments. Kinetic curves of virus growth were drawn using the GraphPad culture supernatants at P15 and P20 were harvested for RT-PCR analysis, as described in 156 Subheading 2.4. Two RT-PCR products were detected by agarose gel electrophoresis. 157

3.1. rCDV-S1 is rescued from its cDNA clone 159

The T7 RNA polymerase-expressing BSR-T7/5 cell line was used for co-transfection to 160 recover the competent rCDV-S1 from its cDNA clone. The CDV infection-permissive VDS cell 161 line was used for blind passages of rescued viruses. The cytopathic effect (CPE), local cell-to-cell 162 fusion, appeared on the VDS cell monolayer at P2 (Fig. 1D, P2 ). The typical syncytium formation 163 was also visible during serial blind passages (Fig. 1D, P6 and P20). 164

The P10 rCDV-S1 was analyzed by RT-PCR to confirm its identity. An expected band of 166 amplicon size (2343 bp) was observed only on the RT-PCR lane by agarose gel electrophoresis 167 ( Fig. 1E , Lane RT-PCR). As a control, PCR analysis (Fig. 1E , Lane PCR) showed no 168 contamination of cDNA clone affecting RT-PCR detection. The identity of rCDV-S1 was 169 confirmed by Sanger sequencing.

The S1 ORF underwent codon optimization for improving expression of the S1 subunit. The 178 culture supernatant of P10 rCDV-S1 was analyzed by mass spectrometry, exhibiting six S1 179 subunit-specific peptide sequences matching to the MS/MS spectra (Fig. 2B) (Fig. 2C) , all of which demonstrated that the S1 subunit could be 182 expressed by the recombinant virus in vitro. 183 3.5. rCDV-S1 replicates more slowly than wild-type strain does 184

To examine multi-step growth curve of the rCDV-S1 in vitro, VDS cells were infected with 185 the P15 rCDV-S1 at MOI of 0.0002. The rCDV-S1-induced syncytia were observable at 24 hpi, 186 and exacerbated over time to cause intercellular hyperfusogenicity at 48 hpi ( Fig. 3A ). At each 187 indicated time point, virus-infected supernatant was separately collected and titrated in VDS cells. 188

The growth curve of rCDV-S1 was compared with that of the wt-CDV (Fig. 3B ). Both viruses 189 exhibited different growth kinetics: the rCDV-S1 replicated more slowly within 24 hpi, but 190 maintained a higher titer level than the wt-CDV did from 48 to 96 hpi. The rCDV-S1 reached its 191 peak titer (4.4 × 10 4 TCID50/mL) at 48 hpi. 192

To test genetic stability of the S1 subunit, the rCDV-S1 was serially passaged in VDS cells 194 for a total of twenty times. The RT-PCR showed that 2343-bp-specific products were separately 195 amplified from RNA samples of P15 and P20 progenies (Fig. 3C ). Both RT-PCR products were 196 confirmed by Sanger sequencing, indicating no fragment deleted from the sequence of S1 subunit. speculate that the full-length ORF of S protein is too long (3822 nt) to be accommodated in a 219 would be impacts on viral replication and on S protein expression to some extent. 221

The S1 subunit is responsible for virus binding to the host cell receptor. After proteolytic 222 virus activation, the S1 subunit offers additional epitopes with antibody exposure. Therefore, S1 223 subunit-based vaccines would be more efficacious than the existing ones [29] . Indeed, recent 224 studies indicated that the S1 subunit could also induce robust immune responses in vivo [30] [31] , 225 and furthermore elicit much higher IgG and IgA antibody levels than the RBD does in immunized 226 mice [32] . Therefore, the S1 subunit was selected as antigen sequence for constructing the 227 recombinant CDV in this study. 228

The wild-type CDV QN strain was a virulence-attenuating vaccine candidate that had been 229 developed in our laboratory previously. In order to construct a safe and effective recombinant 230 CDV, the antigenome sequence of QN strain was used as a backbone for constructing the 231 rCDV-S1 cDNA clone. To enhance protein expression, the full-length ORF of S1 subunit was 232 subjected to codon optimization based on human cells, and flanked by the Kozak sequence at its 5′ 233 end. The P/M intergenic region served as an insertion site for introduction of the foreign sequence 234 into the CDV cDNA clone. The rCDV-S1 was rescued from BSR-T7/5 cells and passaged in VDS 235 cells. Generally, wt-CDV infection induces typical syncytium formation on VDS cells. Such a 236 phenotype was unobservable, and alternatively, slight cell-to-cell fusion sporadically appeared on 237 rCDV-S1-infected VDS cell monolayers during initial blind passages (Fig. 1D, P2 and P5 ). The 238 typical syncytium formation was invisible until the sixth passaging (Fig. 1D, P6 ). Even so, the 239 RT-PCR assay was necessary for detecting the rCDV-S1 sequence, and the PCR assay was 240 simultaneously carried out to eliminate the possibility of potential interference caused by residual 241 cDNA clone plasmids. Besides the RT-PCR detection, the IFA confirmed successful recovery of 242 the competent rCDV-S1. 243

The foreign sequence was demonstrated to be relatively stable during twenty viral passages in 244 vitro, while a few point mutations were identified in the rCDV-S1 genome by Sanger sequencing 245 (data not shown). Due to the absence of S1 subunit-specific antibody in our laboratory, the 246 expression of S1 subunit was qualitatively analyzed by mass spectrometry. Eliminating 247 non-specific peptide sequences of S1 subunit that were identical to those of the Vero cell line, a 248 total of six specific peptide sequences separately matched to their MS/MS spectra ( Fig. 2B and C) , 249 demonstrating that the rCDV-S1 was able to express the S1 subunit in vitro. Unfortunately, the 250 expression of S1 subunit was not subjected to semi-quantitative analysis by Western blot in this 251 study, owing to the lack of S1 subunit-specific antibody. 252 Generally, a high expression level of foreign antigen is not always advantageous for a 253 virus-vectored vaccine to induce immune responses in vivo. In other words, a foreign antigen 254

should be expressed at a proper, but not high, level in hosts [33] . The S1 subunit ORF is a foreign 255 sequence, or a nonstructural gene, for the recombinant virus. Its introduction theoretically reduces 256 the efficiency of viral replication. Indeed, the rCDV-S1 was demonstrated not only to grow more 257 slowly, but also to reach a lower peak titer than the wt-CDV to do (Fig. 3B ). This will be one of 258 major challenges on large-scale production of rCDV-S1. This problem may be alleviated or even 259 be solved by production of virus in suspension cells cultured in a particular bioreactor [34] . If 260 proven to be efficient in resisting both CDV and SARS-CoV-2 in vivo, the rCDV-S1 would be a 261 potential vaccine candidate for clinical tests in minks, which are highly susceptible to CDV and IFA of rCDV-S1-infected cells MS/MS spectra on peptide identifications of S1 subunit Full-length aa sequence of S1 subunit 

COVID-19) Weekly Epidemiological Update and Weekly Operational 273 Update

Zoonotic and reverse 276 zoonotic events of SARS-CoV-2 and their impact on global health

COVID-19 and veterinarians for one health, zoonotic-and reverse-zoonotic